Evidence map›Paper›PMID 39621905›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

C9orf72-linked arginine-rich dipeptide repeats aggravate pathological phase separation of G3BP1.

Margot Van Nerom, Junaid Ahmed, Tamas Lazar, Attila Meszaros, Quentin Galand, Wim De Malsche, Joris Van Lindt, Rita Pancsa, Dominique Maes, Peter Tompa

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Pharmacological modulation of stress granulesFrontiers in pharmacology · 2026
    Review
  8. Targeting G3BP1 Condensate Topology Promotes Stress Granule Assembly via mAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Margot Van NeromStructural Biology Brussels, Bio-engineering Department, Vrije Universiteit Brussel, Elsene 1050, Belgium.ORCID 0000-0001-8554-4741
Junaid AhmedStructural Biology Brussels, Bio-engineering Department, Vrije Universiteit Brussel, Elsene 1050, Belgium.ORCID 0000-0003-3846-6415
Tamas LazarStructural Biology Brussels, Bio-engineering Department, Vrije Universiteit Brussel, Elsene 1050, Belgium.
Attila MeszarosStructural Biology Brussels, Bio-engineering Department, Vrije Universiteit Brussel, Elsene 1050, Belgium.ORCID 0000-0002-4578-4879
Quentin GalandStructural Biology Brussels, Bio-engineering Department, Vrije Universiteit Brussel, Elsene 1050, Belgium.
Wim De MalscheDepartment of Chemical Engineering, Vrije Universiteit Brussel, Elsene 1050, Belgium.
Joris Van LindtStructural Biology Brussels, Bio-engineering Department, Vrije Universiteit Brussel, Elsene 1050, Belgium.
Rita PancsaInstitute of Molecular Life Sciences, Hungarian Research Network, Research Centre for Natural Sciences, Budapest 1117, Hungary.ORCID 0000-0003-0849-9312
Dominique MaesStructural Biology Brussels, Bio-engineering Department, Vrije Universiteit Brussel, Elsene 1050, Belgium.ORCID 0000-0002-9179-3186
Peter TompaStructural Biology Brussels, Bio-engineering Department, Vrije Universiteit Brussel, Elsene 1050, Belgium.

Funding

Agentschap Innoveren en Ondernemen (VLAIO) HBC.2022.0194EC | Horizon 2020 Framework Programme (H2020) 778247EC | Horizon 2020 Framework Programme (H2020) 952334European Space Agency (ESA) A0-2004-070Fonds Wetenschappelijk Onderzoek (FWO) 11D2522NFonds Wetenschappelijk Onderzoek (FWO) FWOSB77Magyar Tudományos Akadémia (MTA) BO/00174/22National Research, Development and Innovation Office FK-142285National Research, Development and Innovation Office K124670National Research, Development and Innovation Office K131702Tempus Közalapítvány (TPF) 184018Vrije Universiteit Brussel (VUB) SRP51
6 · The paper itself

Abstract

The toxic effects of C9orf72-derived arginine-rich dipeptide repeats (R-DPRs) on cellular stress granules in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia remain unclear at the molecular level. Stress granules are formed through the switch of Ras GTPase-activating protein-binding protein 1 (G3BP1) by RNA from a closed inactive state to an open activated state, driving the formation of the organelle by liquid-liquid phase separation (LLPS). We show that R-DPRs bind G3BP1 a thousand times stronger than RNA and initiate LLPS much more effectively. Their pathogenic effect is underscored by the slow transition of R-DPR-G3BP1 droplets to aggregated, ThS-positive states that can recruit ALS-linked proteins hnRNPA1, hnRNPA2, and TDP-43. Deletion constructs and molecular simulations show that R-DPR binding and LLPS are mediated via the negatively charged intrinsically disordered region 1 (IDR1) of the protein, allosterically regulated by its positively charged IDR3. Bioinformatic analyses point to the strong mechanistic parallels of these effects with the interaction of R-DPRs with nucleolar nucleophosmin 1 (NPM1) and underscore that R-DPRs interact with many other similar nucleolar and stress-granule proteins, extending the underlying mechanism of R-DPR toxicity in cells. Our results also highlight characteristic differences between the two R-DPRs, poly-GR and poly-PR, and suggest that the primary pathological target of poly-GR is not NPM1 in nucleoli, but G3BP1 in stress granules in affected cells.

Indexed as

Amyotrophic Lateral SclerosisArginineC9orf72 ProteinDipeptidesDNA HelicasesNucleophosminPoly-ADP-Ribose Binding ProteinsRNA HelicasesRNA Recognition Motif ProteinsDNA-Binding ProteinsFrontotemporal DementiaHeterogeneous Nuclear Ribonucleoprotein A1HumansPhase SeparationProtein BindingStress GranulesArginineC9orf72 ProteinC9orf72 protein, humanDipeptidesDNA-Binding ProteinsDNA HelicasesG3BP1 protein, humanHeterogeneous Nuclear Ribonucleoprotein A1hnRNPA1 protein, humanNPM1 protein, humanNucleophosminPoly-ADP-Ribose Binding ProteinsRNA HelicasesRNA Recognition Motif ProteinsTARDBP protein, humanG3BP1liquid–liquid phase separationneurodegenerative diseaserepeat-expansion diseasestress granules

Identifiers

PMID39621905
PMCPMC11648655

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.